-
admin
Posts
Beong-Soo Kim Unanimously Elected 13th President of USC
Visionary Leader Beong-Soo Kim to Advance USC’s National and Global Excellence LOS ANGELES, Feb. 5, 2026 /PRNewswire/ — The Board of Trustees for the University...
/UPDATE FOR COMPLETENESS — Office of the Chair of the International AI Safety Report/
In the news release, 2026 International AI Safety Report Charts Rapid Changes and Emerging Risks, issued on February 3 by Office of the Chair of...
WeShop Announces Retail Partnerships with StubHub, Vivid Seats, SeatGeek and Event Tickets Centre Helping Shoppers Gift Experiences this Valentine’s Day
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) — WeShop Holdings Limited (“WeShop” or the “Company”) (NASDAQ: WSHP), the world’s first community-owned social commerce platform, today...
Experience Truly Natural Results: Aesthetics International Leads the Region with Expressive Botox Expertise
The Era of “Invisible” Enhancements: Aesthetics International Introduces Expressive Botox to Dubai’s Elite Wellness Scene DUBAI, United Arab Emirates, Feb. 04, 2026 (GLOBE NEWSWIRE) —...
Redefining Refined Living: JASIWAY’s 2026 Space-Smart Furniture Series
Sheridan, WY, Feb. 04, 2026 (GLOBE NEWSWIRE) — As contemporary living spaces grow smaller and the demand for refined, versatile lifestyles continues to rise, JASIWAY...
CREDIT AGRICOLE SA: Fourth quarter 2025 and full-year 2025 results – DYNAMIC ACTIVITY AND STRONG RESULTS IN 2025
DYNAMIC ACTIVITY AND STRONG RESULTS IN 2025 CRÉDIT AGRICOLE S.A. CRÉDIT AGRICOLE GROUP €m 2025 Var....
C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD)...
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that...
Avalo Therapeutics to Participate in Upcoming Investor Conferences
WAYNE, Pa., Feb. 04, 2026 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for...
Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
REDWOOD CITY, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating...
